News

A new discovery about dangerous C. difficile diarrhea has identified a new way that the bacteria – and possibly others like it – cause severe disease. C. diff is the most common hospital-acquired infection and estimated to result in 453,000 cases per year, with 29,300 associated deaths.

Researchers have published new findings showing that the DNA of the tube anemone does what few other species' mitochondrial genomes have been shown to do. It defies the classic doughnut shape it "should" be in and is arranged in several fragmented pieces, the number of which vary depending on the species.

UA researchers are developing a tool to calculate the likelihood of traumatic brain injury after a vehicle collision, using an approach that fuses experimental and computational data.

When a protein named "Merlin" fails to do its job, people can develop slow-growing, life-disrupting auditory nerve tumors that can disrupt their hearing and balance. Now scientists at Cincinnati Children's have discovered much more about how Merlin does its job – by working behind the scenes through a network of more than 50 other proteins.

Researchers have uncovered more evidence that the key to longevity resides in a gene, SIRT6.

Jefferson researchers show a gene called gasdermin E, which is downregulated in many cancers, aids cells in dying in an unexpected way, and may also suppress tumor growth.

University of Texas at Dallas scientists have demonstrated that the growth rate of the majority of lung cancer cells relates directly to the availability of a crucial oxygen-metabolizing molecule. Researchers have engineered and extensively characterized new molecules aimed at starving the cancer cells of the molecule that allows them to proliferate so quickly.

A new study reveals that many people with cancer use marijuana, and rates of use in the U.S. have increased over time.

An NIH grant has been awarded to a group studying "crista" – inner-ear vestibular structures that are relatively under-studied, but are crucial for balance. The research group hopes that

Researchers have discovered that triple-negative breast cancer (TNBC) cells can develop resistance to frontline, or neoadjuvant, chemotherapy not by acquiring permanent adaptations, but rather transiently turning on molecular pathways that protect the cells.